Evidence map›Paper›PMID 40517145›Full record

ArticleEuropean biophysics journal : EBJ2026

Structural adaptability of SARS-CoV-2 Nsp1 with the host network.

Monikaben Padariya, Ted Hupp, Umesh Kalathiya

Abstract read
In one paragraph

Article in European biophysics journal : EBJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Monikaben PadariyaInternational Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822, Gdansk, Poland. monikaben.padariya@ug.edu.pl.
Ted HuppInternational Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822, Gdansk, Poland.
Umesh KalathiyaInternational Centre for Cancer Vaccine Science, University of Gdansk, Ul. Kładki 24, 80-822, Gdansk, Poland. umesh.kalathiya@ug.edu.pl.ORCID http://orcid.org/0000-0001-7757-6962

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 non-structural protein 1 (Nsp1) acts at multiple points toward the host cell to trigger its mRNA cleavage and decay. Nsp1 is found binding with the 40S ribosomal subunit and inhibiting the translation process, as well as docking with different cyclophilins. Herein, we evaluated the structural physicochemical properties of SARS-CoV-2 Nsp1 protein implementing different computational techniques. The Nsp1 was found to form a structured α-helical C-terminal region, following a conformational switch at residue S166 that is necessary for binding the 40S ribosome subunit. Similarly, the presence of cyclophilins stabilizes the Nsp1 C-terminus making a tilt movement at position 166. In the 40S ribosome-Nsp1 machinery, both the ribosomal uS3 and eS30 components were found equally interacting with Nsp1, which guided construction of their pharmacophores. Among a set of studied cyclophilins, FKBP1B showed the highest affinity with Nsp1 and PPIH made least interactions. The majority of cyclophilins dock to the conserved Nsp1 loop or linker region, which connects the C-terminus to the central domain. Our findings revealed that Nsp1 has a versatile C-terminus region which changes its conformations with respect to its host binding partner. Identified novel binding sites within the Nsp1 can assist in understanding its networking (in current or future such infections), as well as support drug discovery programs aimed at targeting the coronavirus family.

Indexed as

SARS-CoV-2Viral Nonstructural ProteinsCOVID-19HumansMolecular Docking SimulationProtein BindingORF1ab polyprotein, SARS-CoV-2Viral Nonstructural Proteins40S ribosomeCyclophilinsLeader proteinNsp1Protein–protein interactionsSARS-CoV-2

Identifiers

PMID40517145
PMCPMC12929329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.